Anti-CD47 drugs have emerged as a promising new class of cancer immunotherapy. CD47 is a "don't eat me" signal that is overexpressed on many cancer cells and prevents macrophages from phagocytosing and clearing them. https://www.coherentmi.com/blog/latest-advancements-paving-new-avenues-for-anti-cd47-drugs-132